Schmidt E, Spindler V, Eming R, Amagai M, Antonicelli F, Baines JF, Belheouane M, Bernard P, Borradori L, Caproni M, Di Zenzo G, Grando S, Harman K, Jonkman MF, Koga H, Ludwig RJ, Kowalczyk AP, Müller EJ, Nishie W, Pas H, Payne AS, Sadik CD, Seppänen A, Setterfield J, Shimizu H, Sinha AA, Sprecher E, Sticherling M, Ujiie H, Zillikens D, Hertl M, Waschke J

J. Invest. Dermatol.. 2017 Apr;:

Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes.

Riani M, Le Jan S, Plée J, Durlach A, Le Naour R, Haegeman G, Bernard P, Antonicelli F

J. Allergy Clin. Immunol.. 2017 Mar;139(3):863-872.e3

Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.

Bernard P, Antonicelli F

Am J Clin Dermatol. 2017 Feb;:

Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines.

Hentati-Kallel M, Le Jan S, Bernard P, Antonicelli F, Trussardi-Régnier A

Int. J. Oncol.. 2017 Feb;50(2):717-726

A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis.

Loget J, Plee J, Antonicelli F, Bernard P

J Eur Acad Dermatol Venereol. 2016 Oct;:

Ethanolic Extract of Algerian Propolis and Galangin Decreased Murine Melanoma T.

Benguedouar L, Lahouel M, Gangloff SC, Durlach A, Grange F, Bernard P, Antonicelli F

Anticancer Agents Med Chem. 2016 ;16(9):1172-83

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.

Plée J, Le Jan S, Giustiniani J, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, Aubin F, Antonicelli F, Bernard P

Sci Rep. 2015 Dec;5:18001

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.

Mombelli S, Cochaud S, Merrouche Y, Garbar C, Antonicelli F, Laprevotte E, Alberici G, Bonnefoy N, Eliaou JF, Bastid J, Bensussan A, Giustiniani J

Sci Rep. 2015 Jul 8;5:11874

Fiche personne Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Pr ANTONICELLI Franck

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Publications

The elastin peptide VGVAPG increases CD4 T-cell IL-4 production in patients with chronic obstructive pulmonary disease.

Matrix remodeling and MMP expression/activation is associated with hidradenitis suppurativa skin inflammation.

Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid.

Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid.

IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid.

NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay.

The Interleukin-17 Family of Cytokines in Breast Cancer.

Association of Transient Palmoplantar Keratoderma With Clinical and Immunologic Characteristics of Bullous Pemphigoid.

Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus.

Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse.

Biomarkers related to bullous pemphigoid activity and outcome.

Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.

Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.